JP2012529452A5 - - Google Patents

Download PDF

Info

Publication number
JP2012529452A5
JP2012529452A5 JP2012514393A JP2012514393A JP2012529452A5 JP 2012529452 A5 JP2012529452 A5 JP 2012529452A5 JP 2012514393 A JP2012514393 A JP 2012514393A JP 2012514393 A JP2012514393 A JP 2012514393A JP 2012529452 A5 JP2012529452 A5 JP 2012529452A5
Authority
JP
Japan
Prior art keywords
semi
solid
ala
solid composition
pharmaceutical product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012514393A
Other languages
English (en)
Japanese (ja)
Other versions
JP5840604B2 (ja
JP2012529452A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/003532 external-priority patent/WO2010142457A1/en
Publication of JP2012529452A publication Critical patent/JP2012529452A/ja
Publication of JP2012529452A5 publication Critical patent/JP2012529452A5/ja
Application granted granted Critical
Publication of JP5840604B2 publication Critical patent/JP5840604B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012514393A 2009-06-11 2010-06-11 半固体組成物および医薬品 Active JP5840604B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09251537 2009-06-11
EP09251537.8 2009-06-11
PCT/EP2010/003532 WO2010142457A1 (en) 2009-06-11 2010-06-11 Semi-solid compositions and pharmaceutical products

Publications (3)

Publication Number Publication Date
JP2012529452A JP2012529452A (ja) 2012-11-22
JP2012529452A5 true JP2012529452A5 (https=) 2013-08-08
JP5840604B2 JP5840604B2 (ja) 2016-01-06

Family

ID=41213323

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012514393A Active JP5840604B2 (ja) 2009-06-11 2010-06-11 半固体組成物および医薬品

Country Status (19)

Country Link
US (2) US20120136055A1 (https=)
EP (2) EP2440199B1 (https=)
JP (1) JP5840604B2 (https=)
KR (2) KR101797780B1 (https=)
CN (1) CN102458388B (https=)
AU (1) AU2010257753B2 (https=)
CA (1) CA2763923C (https=)
CL (1) CL2011003094A1 (https=)
DK (1) DK2440199T3 (https=)
ES (2) ES2821831T3 (https=)
HU (1) HUE026911T2 (https=)
MX (1) MX2011013127A (https=)
NZ (1) NZ596943A (https=)
PL (1) PL2440199T3 (https=)
RU (1) RU2526803C2 (https=)
SG (1) SG176688A1 (https=)
SI (1) SI2440199T1 (https=)
WO (1) WO2010142457A1 (https=)
ZA (1) ZA201109126B (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2790827A1 (en) * 2010-03-01 2011-09-09 Photocure Asa Cosmetic compositions
JP5991970B2 (ja) 2010-07-09 2016-09-14 フォトキュア エイエスエイ 光力学的治療または光力学的診断で使用する乾燥組成物および当該乾燥組成物を含む装置
RU2615870C2 (ru) 2011-12-19 2017-04-11 ФотоКьюэр АСА Устройство облучения
CN102670577B (zh) * 2012-05-18 2018-04-13 上海复旦张江生物医药股份有限公司 一种光敏剂组合物、其使用方法及用途
US20140067024A1 (en) 2012-08-30 2014-03-06 Photocure Asa Dual panel photodynamic therapy lamp
GB201221123D0 (en) 2012-11-23 2013-01-09 Photocure As Device for photodynamic treatment
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
JP6363115B2 (ja) * 2013-02-28 2018-07-25 ミラ ファーマ コーポレイション 注射可能局所麻酔半固体製剤およびその組成物
GB201306369D0 (en) 2013-04-09 2013-05-22 Photocure As Irradiation device
AU2015253045B2 (en) * 2014-04-30 2020-07-16 Allergan, Inc. Formulations of biologics for intravesical instillation
CZ307444B6 (cs) * 2015-04-22 2018-08-29 Jakub Rak Mukoadhezivní polymerní film pro fotosenzitivní terapii v ústní dutině s obsahem fotosenzitizérů
BR112018011965A2 (pt) 2015-12-17 2018-12-04 Photocure Asa método de terapia fotodinâmica (pdt) para câncer de bexiga
GB201522309D0 (en) 2015-12-17 2016-02-03 Photocure Asa Use
GB201522398D0 (en) 2015-12-18 2016-02-03 Photocure As Device for photodynamic therapy
WO2017168416A1 (en) * 2016-03-28 2017-10-05 Vidac Pharma Ltd. Stable pharmaceutical compositions for topical administration and uses thereof
US11884784B2 (en) 2016-05-10 2024-01-30 North Carolina State University Photodynamic compositions, methods of making, and uses thereof
WO2017196961A1 (en) * 2016-05-10 2017-11-16 North Carolina State University Photodynamic compositions, methods of making, and uses thereof
GB2546128A (en) * 2016-09-28 2017-07-12 Photocure Asa Pharamaceutical compositions comprising hexaminolevulinic acid and methods of using the same
EP4299395B1 (en) * 2017-05-01 2025-10-15 Cummins, Inc. System and method for controlling energy generation in a hybrid powertrain
DK3641882T3 (da) * 2017-06-21 2023-12-18 Photocure Asa Fremgangsmåde til fremstilling af en flydende farmaceutisk sammensætning og indretning til anvendelse i en sådan fremgangsmåde
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
GB201808571D0 (en) * 2018-05-24 2018-07-11 Douglas Pharmaceuticals Ltd Pharmaceutical compositions
EP3846852A4 (en) 2018-09-07 2022-06-15 R.P. Scherer Technologies, LLC Solid or semisolid lipid based dosage form stabilization through curing and addition of low hlb surfactant(s)
IL285384B2 (en) 2019-02-13 2024-11-01 Alpheus Medical Inc Non-invasive sonodynamic therapy
MX2021014512A (es) 2019-05-29 2022-02-11 Sonalasense Inc Sonosensibilizacion.
CN110575612A (zh) * 2019-09-27 2019-12-17 赵志国 女用光动力凝胶封包敷料装置
WO2022032283A2 (en) 2020-08-07 2022-02-10 Alpheus Medical, Inc. Ultrasound arrays for enhanced sonodynamic therapy for treating cancer
TW202600126A (zh) * 2024-03-12 2026-01-01 大陸商上海亞虹醫藥科技有限公司 用於子宮頸疾病或病症之光動力療法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
JPH08175986A (ja) * 1994-09-20 1996-07-09 Johnson & Johnson Medical Inc 経皮活性を示す5−アミノレブリン酸含有薬学組成物
US7530461B2 (en) * 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
ATE202076T1 (de) 1995-03-10 2001-06-15 Photocure Asa Ester der 5-aminolevulinsäure als mittel zur photosensibilisierung in der chemotherapie
EP0844876A4 (en) * 1995-08-14 1999-12-01 Univ California ENDOMETRIAL ABLATION USING PHOTODYNAMIC TREATMENT WITH GREEN PORPHYRINS
DE10003620A1 (de) * 2000-01-28 2001-08-02 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln
US20020132035A1 (en) * 2001-01-10 2002-09-19 Dov Tamarkin Synthetic fat composition
GB0018527D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Composition
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds
GB0118251D0 (en) 2001-07-26 2001-09-19 Photocure Asa Method
US7264629B2 (en) * 2001-11-09 2007-09-04 Qlt, Inc. Photodynamic therapy for the treatment of hair loss
EP1312353A1 (en) 2001-11-16 2003-05-21 Ecole Polytechnique Federale De Lausanne (Epfl) Method for hair removal
US20040009212A1 (en) * 2002-01-30 2004-01-15 Pharma Power Biotec Co. Ltd. Mucoadhesive thermoresponsive medicament-carrier composition
CA2457214A1 (en) * 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
GB0424833D0 (en) 2004-11-10 2004-12-15 Photocure Asa Method
DE102005019628A1 (de) * 2005-04-26 2006-11-09 Technische Universität Braunschweig Formulierung zur dermalen Anwendung
GB0700580D0 (en) * 2007-01-11 2007-02-21 Photocure Asa Use
GB0724279D0 (en) 2007-12-12 2008-01-23 Photocure Asa Use
GB0900461D0 (en) 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device

Similar Documents

Publication Publication Date Title
JP2012529452A5 (https=)
RU2011150919A (ru) Полутвердые композиции и фармацевтические продукты
CN107151235B (zh) 噻二唑烷二酮基gsk3抑制剂在调节精子运动能力中的用途
ES2869250T3 (es) Cápsula de estradiol soluble para inserción vaginal
RU2014112548A (ru) Применение 5-аминолевулиновой кислоты и ее производных в твердой форме для фотодинамического лечения и диагностики
RU2560879C2 (ru) Cпособ профилактики передающихся половым путем вирусных заболеваний, лекарственное средство, способ получения лекарственного средства, фармацевтическая композиция для местного применения и презерватив
JP2008530022A (ja) 免疫反応調節物質を含む水性ゲル処方物
JPWO1993008804A1 (ja) プロスタグランジン化合物含有直腸または膣投与用製剤
JP2013523693A5 (https=)
WO2014041378A2 (en) Topical pharmaceutical composition
ES2653313T3 (es) Formulaciones de imiquimod con concentración de dosificación menor y regímenes de dosificación cortos para el tratamiento de verrugas genitales y perianales
JP2013514979A5 (https=)
ES2319626T3 (es) Farmaco para el tratamiento de enfermedades tumorales y de la piel virales.
JPS5896036A (ja) 新ナフタレン誘導体の製法
MX351117B (es) Formulacion de la sal acido glicirricinico en gel termorreversible y acido tricloroacetico para su aplicacion en el tracto genital de mujeres y varones con lesiones causadas por el virus del papiloma humano y cancer en los mismos.
Kim Pathogenesis and management guideline of dysmenorrhea
US20090291140A1 (en) Treatment of dysmenorrhea via transdermal administration of nonsteroidal anti-inflammatory drugs
ES2569395T3 (es) Fármaco que contiene miristato de isopropilo y una catequina
RU2014105453A (ru) Предупреждение рецидивов сужения уретры после классического лечения
CN103877084B (zh) 一种治疗肛周溃疡的外用药物
ES2938358T3 (es) Formulación farmacéutica para el tratamiento de modificaciones inflamatorias del recto
RU2747987C1 (ru) Композиция для лечения латентной и субклинической папилломавирусной инфекции шейки матки и способ ее применения
KR20160072829A (ko) 테노포비어, 항균제 및 선택적으로 시클로피록스를 포함하는 국소 약학 조성물
CN110831577A (zh) 包含抗病毒化合物的阴道内施用型装置
EP2968127A1 (en) Low-glycerin formulations for hiv treatment and prevention